a16z Capital Management, L.L.C.
CIK 1540358
13F filing for Q2 2026・No. 461
- Holdings
- US$14.21B
- Quarter change
- +US$12.92B
- Entries
- 19
- Net bought (estimate)
- +US$12.61B
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 4
- Sold out 1
- Cut 3
- Added 0
- Corporate actions 2
- Unchanged 12
Largest holdings
19 stocks worth US$14.21B, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| SPCXSPACE EXPLORATION TECHN CORPCLASS A COM STK | New | 74,855,020 | US$12.79B | 89.97% |
| NAVAN INCCL A | Unchanged | 28,218,676 | US$645.36M | 4.54% |
| RVMDREVOLUTION MEDICINES INCCOM | Unchanged | 921,099 | US$172.5M | 1.21% |
| METAMetaCL A | Unchanged | 212,531 | US$119.72M | 0.84% |
| FIGFIGMA INCCLASS A COM STK | Cut | 5,983,308 | US$108.24M | 0.76% |
| BIOAGE LABS INCCOM | Unchanged | 3,233,170 | US$79.24M | 0.56% |
| XYZBLOCK INCCL A | Unchanged | 1,016,697 | US$77.27M | 0.54% |
| ERASCA INCCOM | Unchanged | 2,862,500 | US$52.44M | 0.37% |
| MAZEMAZE THERAPEUTICS INCCOM | Unchanged | 1,702,225 | US$50.79M | 0.36% |
| DAMORA THERAPEUTICS INCCOM NEW | Unchanged | 1,236,157 | US$32.15M | 0.23% |
Sign in (free) to see its 19 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.